Document is current
Any future updates will be listed below
-
Authors
Ye, Zilu https://orcid.org/0000-0001-8829-6579
Sabatier, Pierre https://orcid.org/0000-0002-2734-1791
van der Hoeven, Leander https://orcid.org/0000-0003-4005-580X
Lechner, Maico Y. https://orcid.org/0009-0006-7471-6003
Phlairaharn, Teeradon https://orcid.org/0000-0001-6031-0578
Guzman, Ulises H.
Liu, Zhen
Huang, Haoran
Huang, Min
Li, Xiangjun
Hartlmayr, David
Izaguirre, Fabiana https://orcid.org/0009-0008-5335-0780
Seth, Anjali
Joshi, Hiren J. https://orcid.org/0000-0002-8192-2829
Rodin, Sergey
Grinnemo, Karl-Henrik
Hørning, Ole B.
Bekker-Jensen, Dorte B.
Bache, Nicolai
Olsen, Jesper V. https://orcid.org/0000-0002-4747-4938
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF14CC0001, NNF21OC0072070, NNF22OC0076899)
Novo Nordisk (CELFFI-2022-002843)
Innovationsfonden (ERA-PerMed-JTC2022-OVA-PDM, ERA-PerMed-JTC2022-OVA-PDM)
Chinese Academy of Medical Sciences (2023-RC180-03, 2022-I2M-2-004, 2023-I2M-2-005)
Vetenskapsrådet (2022-00323)
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 4 November 2024
First Online: 16 January 2025
Competing interests
: D.B.B.-J. and N.B. are employees of Evosep Biosystems. D.H., F.I. and A.S. are employees of Cellenion SASU. H.H., M.H. and X.L. are employees of Thermo Fisher Scientific. The other authors declare no competing interests.
